Overview
- 120 inspections across 118 sites are on record.
- 556 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2018-04-03.
At a glance
Inspections
120
Sites
118
Observations
556
Career since
Oct 2010
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Gland Chemicals Private Limited | 3 Apr 2018 | Human Drugs | View 483 → |
| Somerset Therapeutics Private Limited | 5 Dec 2017 | Human Drugs | On file |
| Cilag AG | 19 May 2017 | Medical Devices & Rad Health | View 483 → |
| Novartis Pharma Stein AG | 9 May 2017 | Human Drugs | View 483 → |
| Delta Laboratories Pty Ltd | 31 Mar 2017 | Human Drugs | On file |
Sites inspected
Gland Chemicals Private LimitedChennai, India1 insp.
Somerset Therapeutics Private LimitedBengaluru, India1 insp.
Cilag AGSchaffhausen, Switzerland1 insp.
Novartis Pharma Stein AGStein Ag, Switzerland1 insp.
Delta Laboratories Pty LtdSomersby, Australia1 insp.
Co-investigators
Investigators who share inspections with this person.
Zachary A Bogorad5 shared
Binh T Nguyen3 shared
Linda Thai3 shared
Kimberly M Lichter3 shared
Rochelle A Rolnik3 shared
Don H Bark2 shared
Xiomara Copeland2 shared
Stephanie D Crockett2 shared
Susanne M Richardson2 shared
Jogy George2 shared
Full investigator report
Get the verbatim findings behind Ademola O Daramola's 556 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site